Department of Surgery, Faculty of Medicine Ragama, University of Kelaniya, Kelaniya, Sri Lanka.
Surg Endosc. 2019 Jan;33(1):179-183. doi: 10.1007/s00464-018-6291-0. Epub 2018 Jun 25.
Transverse abdominal plane block (TAP) is a new technique of regional block described to reduce postoperative pain in laparoscopic cholecystectomy (LC). Recent reports describe an easy technique to deliver local anesthetic agent under laparoscopic guidance.
This randomized control trial was designed to compare the effectiveness of additional laparoscopic-guided TAP block against the standard full thickness port site infiltration. 45 patients were randomized in to each arm after excluding emergency LC, conversions, ones with coagulopathy, pregnancy and allergy to local anesthetics. All cases were four ports LC. Interventions-Both groups received standard port site infiltration with 3-5 ml of 0.25% bupivacaine. The test group received additional laparoscopic-guided TAP block with 20 ml of 0.25% bupivacaine subcostally, between the anterior axillary and mid clavicular lines. As outcome measures the pain score, opioid requirement, episodes of nausea and vomiting and time to mobilize was measured at 6 hourly intervals.
The two groups were comparable in the age, gender, body mass index, indication for cholecystectomy difficulty index and surgery duration. The pain score at 6 h (P = 0.043) and opioid requirement at 6 h (P = 0.026) was higher in the TAP group. These were similar in subsequent assessments. Other secondary outcomes were similar in the two groups.
Laparoscopic-guided transverses abdominis plane block using plain bupivacaine does not give an additional pain relief or other favorable outcomes. It can worsen the pain scores. Pre registration: The trial was registered in Sri Lanka clinical trial registry-SLCTR/2016/011 ( http://www.slctr.lk/trials/357 ).
腹横肌平面阻滞(TAP)是一种新的区域阻滞技术,用于减少腹腔镜胆囊切除术(LC)的术后疼痛。最近的报告描述了一种在腹腔镜引导下给予局部麻醉剂的简单技术。
本随机对照试验旨在比较额外的腹腔镜引导 TAP 阻滞与标准全层切口部位浸润的效果。排除急诊 LC、转化、凝血功能障碍、妊娠和局部麻醉剂过敏的病例后,将 45 例患者随机分为两组。所有病例均采用四孔 LC。干预措施:两组均接受标准切口部位浸润,每处注射 3-5ml 0.25%布比卡因。实验组在腋前线和锁骨中线之间的肋弓下额外接受腹腔镜引导的 TAP 阻滞,注射 20ml 0.25%布比卡因。以 6 小时为间隔,测量疼痛评分、阿片类药物需求、恶心和呕吐发作次数以及活动时间作为结局指标。
两组在年龄、性别、体重指数、胆囊切除术适应证、困难指数和手术时间方面具有可比性。6 小时时疼痛评分(P=0.043)和 6 小时时阿片类药物需求(P=0.026)在 TAP 组更高。在随后的评估中,这些指标在两组之间相似。两组的其他次要结局相似。
使用普通布比卡因的腹腔镜引导 TAP 阻滞并不能提供额外的止痛效果或其他有利结果,反而可能加重疼痛评分。预注册:该试验已在斯里兰卡临床试验注册中心-SLCTR/2016/011(http://www.slctr.lk/trials/357)注册。